Effects of exercise on cardiovascular risk factors in type 2 diabetes: A meta-analysis

Diabetes Care

Volumn 34, Issue 5, 2011, Pages 1228-1237

  Chudyk, Anna ^a,b   Petrella, Robert J ^a,c,d  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c WESTERN UNIVERSITY   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; TRIACYLGLYCEROL;

AEROBIC EXERCISE; BODY COMPOSITION; CARDIOVASCULAR RISK; DYSLIPIDEMIA; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RESISTANCE TRAINING; REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; WAIST CIRCUMFERENCE;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; EXERCISE; HUMANS; RISK FACTORS;

EID: 79956099840     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-1881     Document Type: Review

References (35)

1. World Health Organization. Global Strategy on Diet, Physical Activity and Health: Diabetes. Geneva, World Health Organization, 2006
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053
3. Harris M. Classification, diagnostic criteria, and screening for diabetes. In Diabetes in America. 2nd ed. Bethesda, MD, National Diabetes Data Group, 1995, p. 15 (NIH publ. no. 95-1468)
4. Gerich JE. Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors. Clin Cornerstone 2007;8:53-68 (Pubitemid 351597784)
5. American Heart Association. Diabetes and cardiovascular disease [article online], 2009. Available from http://www.americanheart.org. Accessed 3 October 2009
6. Haffner S, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-234 (Pubitemid 28350165)
7. Bhattacharyya OK, Shah BR, Booth GL. Management of cardiovascular disease in patients with diabetes: the 2008 Canadian Diabetes Association guidelines. CMAJ 2008;179:920-926
8. CDA. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Canadian Journal of Diabetes 2008;32(Suppl. 1):S1-S15
9. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2005. Atlanta, GA, Department of Health and Human Services, Centers for Disease Control and Prevention, 2005
10. Coughlin SS, Pearle DL, Baughman KL, Wasserman A, Tefft MC. Diabetes mellitus and risk of idiopathic dilated cardiomyopathy. The Washington, DC Dilated Cardiomyopathy Study. Ann Epidemiol 1994;4:67-74
11. Stone PH, Muller JE, Hartwell T, et al.; The MILIS Study Group. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. J Am Coll Cardiol 1989;14:49-57 (Pubitemid 19165535)
12. Albright A, Franz M, Hornsby G, et al. American College of Sports Medicine position stand. Exercise and type 2 diabetes. Med Sci Sports Exerc 2000;32:1345-1360
13. Thomas DE, Elliott EJ, Naughton GA. Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev 2006;3:CD002968
14. Snowling NJ, Hopkins WG. Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients: a meta-analysis. Diabetes Care 2006;29:2518-2527 (Pubitemid 44912265)
15. Boulé NG, Haddad E, Kenny GP, Wells GA, Sigal RJ. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 2001;286:1218-1227 (Pubitemid 33015552)
16. Goldberg IJ. Clinical review 124: diabetic dyslipidemia: causes and consequences. J Clin Endocrinol Metab 2001;86:965-971 (Pubitemid 32322966)
17. Nesto RW. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome. Am J Cardiovasc Drugs 2005;5:379-387 (Pubitemid 41584838)
18. He J, Whelton PK. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. J Hypertens Suppl 1999;17(Suppl. 2):S7-S13 (Pubitemid 29397295)
19. Daousi C, Casson IF, Gill GV, MacFarlane IA, Wilding JP, Pinkney JH. Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors. Postgrad Med J 2006;82:280-284
20. Eckel RH. Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1997;96:3248-3250 (Pubitemid 27500134)
21. Aucott LS. Influences of weight loss on long-term diabetes outcomes. Proc Nutr Soc 2008;67:54-59 (Pubitemid 351185357)
22. Cuff DJ, Meneilly GS, Martin A, Ignaszewski A, Tildesley HD, Frohlich JJ. Effective exercise modality to reduce insulin resistance in women with type 2 diabetes. Diabetes Care 2003;26:2977-2982 (Pubitemid 37339486)
23. Yeater RA, Ullrich IH, Maxwell LP, Goetsch VL. Coronary risk factors in type II diabetes: response to low-intensity aerobic exercise. W V Med J 1990;86:287-290
24. Sigal RJ, Kenny GP, Boulé NG, et al. Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med 2007;147:357-369 (Pubitemid 351664536)
25. Jennings AE, Alberga A, Sigal RJ, Jay O, Boulé NG, Kenny GP. The effect of exercise training on resting metabolic rate in type 2 diabetes mellitus. Med Sci Sports Exerc 2009;41:1558-1565
26. Lambers S, Van Laethem C, Van Acker K, Calders P. Influence of combined exercise training on indices of obesity, diabetes and cardiovascular risk in type 2 diabetes patients. Clin Rehabil 2008;22:483-492
27. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-431
28. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853
29. ten Brinke R, Dekker N, de Groot M, Ikkersheim D. Lowering HbA1c in type 2 diabetics results in reduced risk of coronary heart disease and all-cause mortality. Prim Care Diabetes 2008;2:45-49
30. Bloomgarden ZT, Dodis R, Viscoli CM, Holmboe ES, Inzucchi SE. Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy: a meta-regression analysis. Diabetes Care 2006;29:2137-2139 (Pubitemid 44871202)
31. Tin LL, Beevers DG, Lip GY. Systolic vs diastolic blood pressure and the burden of hypertension. J Hum Hypertens 2002;16:147-150 (Pubitemid 34232533)
32. de Mello Meirelles C, Gomes P. Acute effects of resistance exercise on energy expenditure: revisiting the impact of training variables. Rev Bras Med Esporte 2004;10:131-138 (Pubitemid 38811665)
33. Scala D, Mcmillian J, Blessing D, Rozenek R, Stone M. Metabolic cost of a preparatory phase of training in weight lifting: a practical observation. J Appl Sport Sci Res 1987;1:48-52
34. Bloomer RJ. Energy cost of moderate-duration resistance and aerobic exercise. J Strength Cond Res 2005;19:878-882 (Pubitemid 41784046)
35. Pollock M, Gaesser G, Butcher J, et al. American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc 1998;30:975-991